Home / Dabigatran Etexilate / Czechia
CZ ATC B01AE07 · updated 2 Nov 2026
Dabigatran Etexilate shortage in Czechia
Is there a Dabigatran Etexilate shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Dabigatran Etexilate products are reported short in Czechia, the first since 2 Apr 2026. The company estimate for the return is 20 Nov 2026 (latest 11 Dec 2026). Main reason: distribution or logistics.
Also short in Canada, Germany, Italy, Spain, Austria, Belgium, Norway, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | GRIBERO 110MG 110MG CPS DUR 30 | Sandoz s.r.o., Praha | 2 Apr 2026 | 11 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | GRIBERO 110MG 110MG CPS DUR 60 | Sandoz s.r.o., Praha | 11 May 2026 | 11 Dec 2026 | Distribution or logistics Kapacitní/distribuční důvody |
| CZ | GRIBERO 150MG 150MG CPS DUR 60 | Sandoz s.r.o., Praha | 3 Jun 2026 | 20 Nov 2026 | Distribution or logistics Kapacitní/distribuční důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.